h
PSC
reg
®
Home
Browse
All cell lines
All hiPSC lines
All hESC lines
Cell line providers
Research projects
Countries
Diseases
Publications
Clinical studies
Info
About hPSCreg
FAQ
Cell Registration
Glossary
Documents & Governance
Fact Sheets
Naming Tool
Publishing your line
Structures
Registration Summary
Certification
Organoids
API
Export Data
SPARQL Guide
Contact
News
Newsletter Subscription
Privacy Policy
Terms of Use
Imprint
Login
Log-in
Sign up
Forgot your password?
This website uses cookies to keep track of login sessions and for internal Matomo Statistics. See our
Privacy Policy
for details.
This website uses cookies,
learn more
x
UCLi013-A
Registration Summary
:
A
P
E
C
PAX6 p.Asn124Lys
The cell line is
not submitted
yet.
(only basic data is shown)
General
Cell Line
hPSCreg name
UCLi013-A
Cite as:
When citing this cell line, please use the hPSCreg name (see
Naming Tool
) and the corresponding Research Resource ID (RRID).
UCLi013-A (RRID:CVCL_ZA79)
Alternative name(s)
PAX6 p.Asn124Lys
Cell line type
Human induced pluripotent stem cell (hiPSC)
Similar lines
No similar lines found.
Last update
19th January 2021
User feedback
show/hide
Written by
on
Delete
No feedback available yet.
Login
to share your feedback, experiences or results with the research community.
Provider
Generator
University College London (UCL)
External Databases
Cellosaurus
CVCL_ZA79
BioSamples
SAMEA9370377
Wikidata
Q98133850
General Information
Publications
Harding P et al. Generation of human iPSC line (UCLi013-A) from a patient with microphthalmia and aniridia, carrying a heterozygous missense mutation c.372C>A p.(Asn124Lys) in PAX6. Stem cell research. 2021 Mar;51:102184.
Abdolkarimi D et al. PAX6 disease models for aniridia. Indian journal of ophthalmology. 2022 Dec;70(12):4119-4129.
Tamayo A et al. Minigene Splicing Assays and Long-Read Sequencing to Unravel Pathogenic Deep-Intronic Variants in PAX6 in Congenital Aniridia. International journal of molecular sciences. 2023 Jan 13;24(2).
Roshandel Danial et al. Genetic predisposition to ocular surface disorders and opportunities for gene-based therapies. The Ocular Surface. 2023-07-00.
Lima Cunha D et al. Restoration of functional PAX6 in aniridia patient iPSC-derived ocular tissue models using repurposed nonsense suppression drugs. Molecular therapy. Nucleic acids. 2023 Sep 12;33:240-253.
Ilmarinen Tanja et al. Production and Limbal Lineage Commitment of Aniridia Patient-Derived Induced Pluripotent Stem Cells. Stem Cells. 2023-12-14.
Eintracht Jonathan et al. Disruption of common ocular developmental pathways in patient-derived optic vesicle models of microphthalmia. Stem Cell Reports. 2024-06-00.
hIPSC Derivation
General
Login to share your feedback, experiences or results with the research community.